Agilent Technologies, Inc. A

172.79 (0.05) (0.03%) as of 25 Sep
Market cap
$49.0B
P/E
33.9×
Indexes indicate stock being part of an index,
Growth Flags show if company had growth for consecutive years

Agilent Technologies, Inc. (A) P/B ratio

As of 25 September 2026, Agilent Technologies, Inc. (A) trades at a P/B ratio of 6.6×. Over the past ten years it has ranged from 2.4× (January 2015) to 11.0× (September 2021); the current reading is higher than 72% of that period. That is above the Diagnostics & Research industry median of 3.1× and above the Healthcare sector median of 2.5×.

P/B ratio, daily

Annual

Period P/B ratio Change
FY2025 6.2× (3.76%)
FY2024 6.4× 23.23%
FY2023 5.2× (33.32%)
FY2022 7.8× (11.99%)
FY2021 8.9× 32.77%
FY2020 6.7× 33.21%
FY2019 5.0× 10.10%
FY2018 4.5× 0.43%
FY2017 4.5× 35.44%
FY2016 3.3× 8.55%

Quarterly

Period P/B ratio Change
Jul 2026 5.3× 15.83%
Apr 2026 4.6× (17.51%)
Jan 2026 5.5× (10.05%)
Oct 2025 6.2× 20.46%
43 more quarters

Against its own ten years

Low 2.4× High 11.0×
Ten-year median 5.4×
Current reading's percentile 72

P/B ratio against peers

Company P/B ratio
GH Guardant Health, Inc. compare n/m
WAT Waters Corporation compare 2.8×
DGX Quest Diagnostics Incorporated compare 3.4×
A Agilent Technologies, Inc. 6.6×
IQV IQVIA Holdings Inc. compare 7.1×
ILMN Illumina, Inc. compare 14.5×
IDXX IDEXX Laboratories, Inc. compare 25.4×
NTRA Natera, Inc. compare 32.5×
MTD Mettler-Toledo International, Inc. compare 2,372×
Diagnostics & Research industry median 3.1×
Healthcare sector median 2.5×
Market median 1.8×

What P/B ratio is

Price to Book Value tells an investor how much the market pays for a company’s shares relative to the accounting net worth that belongs to common shareholders.

Stock Price ÷ (Common Equity (Total) (latest quarter) ÷ Shares (Basic, Weighted) (latest quarter))

The full definition of P/B ratio →

More on A